Spire Healthcare Group said today that it expects its 2019 earnings to be in line with current guidance and market expectations following ‘positive momentum’ in sales growth.
In a trading update issued ahead of its preliminary results on 5 March, the London-listed private hospital group said growth had been driven by private patient revenues.
It also reported further progress on quality improvement, with 83% of sites now rated good or outstanding compared to 76% in 2018.
Improved cash generation in the second half means the company expects to end the year with reduced debt.
Net bank debt is forecast to down from £372.7m to £330m year-on-year.
Capex is expected to come in at c.£60m in line with prior guidance.
Spire said its performance had been underpinned by continued investment in clinical quality and patient safety.